Interested in becoming an advocate?
Back to main page
Victoza®
Once a day subcutaneous injection
Ozempic (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.
Victoza (generic name: Liraglutide) is a GLP-1 agonist FDA approved for weight management.
How does
Victoza®
work:
- act on brain signaling to reduce food intake
- helps control blood sugar levels by increasing the release of insulin from the pancreas
- slows down food leaving your stomach, thus, keeping you fuller for longer
Common side effects of
Victoza®
- nausea
- vomiting
- decreased appetite
- diarrhea
- stomach (abdominal) pain
- constipation
- indigestion
You can find more information here:
Expected Results:
- Helps control blood sugar levels
- Decreased HgbA1C
- Patients lost on average 5% of initial body weight
Do not take
Victoza®
if you:
- have or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have MEN2
- are pregnant, planning to become pregnant or breastfeeding
- have or have had history of pancreatitis
- history of chronic malabsorption
- history of gallbladder disease
- have a history of gastroparesis or IBD
- are allergic to liraglutide or any of the ingredients* in Victoza
*non-medicinal ingredients in Victoza: Disodium phosphate dihydrate, 1.42 mg; propylene glycol, 14 mg; phenol, 5.5 mg; and water for injection.
Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.